| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/29/2011 | US7915308 Therapeutic methods and compositions involving isoflavones |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 03/29/2011 | CA2460640C Diaryl ether derivatives, salts thereof and immunosuppressive agents using the same |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011034207A1 Partial peptide of lacritin |
| 03/24/2011 | WO2011034192A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011034051A1 Novel cyclic squaramide derivatives |
| 03/24/2011 | WO2010102052A3 Methods of inhibiting photoreceptor apoptosis |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071225 Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071186 Organic compounds |
| 03/24/2011 | US20110071167 Method of treatment of age-related macular degeneration (amd) |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071126 Inhibitors of beta-secretase |
| 03/24/2011 | US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071091 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/24/2011 | US20110071078 Methods for treating neurological deficits |
| 03/24/2011 | US20110070310 Topical ophthalmic pharmaceutical formulation of (2s,3s,4r)-n''-cyano-n-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2h-benzopyran-4-yl)-n'-benzylguanidine |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070236 Use of immunesuppressant receptor |
| 03/24/2011 | US20110070222 Therapeutic Modulation of Ocular Surface Lubrication |
| 03/24/2011 | CA2773597A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298892A2 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 03/23/2011 | EP2298747A1 Triazole derivative or salt thereof |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2297153A1 Limk2 inhibitors, compositions comprising them, and methods of their use |
| 03/23/2011 | EP2297085A2 Substituted arylcyclopentenes as therapeutic agents |
| 03/23/2011 | EP2296682A2 Methods of treating ophthalmic disorders |
| 03/23/2011 | EP2296661A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment |
| 03/23/2011 | EP2296655A1 Quinolynylmethylimidizoles as therapeutic agents |
| 03/23/2011 | EP2296647A2 Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| 03/23/2011 | EP2296640A1 Methods for preventing the development of retinopathy by the oral administration of nnr ligands |
| 03/23/2011 | EP2296632A2 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 03/23/2011 | EP2023918B1 Cyclosporins for the treatment and prevention of ocular disorders |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN101990433A Compounds that enhance atoh-1 expression |
| 03/23/2011 | CN101987862A Sulfamoyl heteroaryl carboxylic ester derivative of glucocorticoids |
| 03/23/2011 | CN101987859A Aryl ammonia sulphonyl sulphonate derivative of glucocorticoid |
| 03/23/2011 | CN101987847A Novel heterocyclic NF-kB inhibitors |
| 03/23/2011 | CN101987173A Traditional Chinese medicine for treating diabetic oculopathy |
| 03/23/2011 | CN101987169A Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus |
| 03/23/2011 | CN101987166A Medicament for treating stye and preparation method thereof |
| 03/23/2011 | CN101987163A Medicine for treating cataract and preparation method thereof |
| 03/23/2011 | CN101987157A Medicine for treating nearsightedness and preparation method thereof |
| 03/23/2011 | CN101987134A Traditional Chinese medicine for treating diabetic retinopathy |
| 03/23/2011 | CN101987109A Ophthalmic composition containing povidone iodine and cyclodextrin included glucocorticoid |
| 03/23/2011 | CN101987104A Ophthalmic composition of heteroaryl sulfamoyl carboxylic ester carbonic anhydrase inhibitor |
| 03/23/2011 | CN101987103A Ophthalmic composition of carbonic anhydrase inhibitor |
| 03/23/2011 | CN101987102A Ophthalmic anti-inflammatory composition of glucocorticoid heteroaryl sulfamoyl carboxylate |
| 03/23/2011 | CN101987101A Anti-inflammatory eye composition with glucocorticoid aromatic sulfamoyl sulfonic acid ester as active ingredient |
| 03/23/2011 | CN101987084A Chitosan-collagen sustained-release eye drop and preparation method |
| 03/23/2011 | CN101433669B Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 03/22/2011 | USRE42243 Synthetic viscoelastic material for ophthalmic applications |
| 03/22/2011 | US7910615 Prophylactic or therapeutic agent for diabetic maculopathy |
| 03/22/2011 | US7910567 Opticin nucleic acid administration reduces blood vessel formation |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2376797C Administration of non oral androgenic steroids to women |
| 03/17/2011 | WO2011030873A1 Benzyl compounds |
| 03/17/2011 | WO2011030868A1 Substituted carbonyl compounds |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |
| 03/17/2011 | WO2011030798A1 8-oxodihydropurine derivative |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110066101 Non-invasive ocular drug delivery |
| 03/17/2011 | US20110065805 Xanthophyll composition containing macular pigments and a process for its preparation |
| 03/17/2011 | US20110065800 Formulations for cathepsin k inhibitors |
| 03/17/2011 | US20110065790 Latanoprost-containing aqueous pharmaceutical composition |
| 03/17/2011 | US20110065774 Chemically modified oligonucleotides and uses thereof |
| 03/17/2011 | US20110065761 Methods of treating nerve-related vision disorders |
| 03/17/2011 | US20110065760 Compounds for the inhibition of rotamases and use thereof |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065698 Novel protein kinase modulators |
| 03/17/2011 | US20110065642 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion |
| 03/17/2011 | US20110065641 Polypeptide and dna thereof useful as a neovascular marker |
| 03/17/2011 | US20110064821 Encapsulation of biologically active agents |
| 03/17/2011 | US20110064811 Solid forms of N-[2,4-BIS(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/17/2011 | US20110064792 Method for Opening Tight Junctions |
| 03/17/2011 | US20110064762 Protein a compositions and methods of use |